Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders
- 1 January 2013
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 324 (1-2), 38-39
- https://doi.org/10.1016/j.jns.2012.09.024
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Brain Involvement in Neuromyelitis Optica Spectrum DisordersArchives of Neurology, 2011
- Impact of rituximab on relapse rate and disability in neuromyelitis opticaMultiple Sclerosis Journal, 2011
- Interferon Beta Treatment in Neuromyelitis OpticaArchives of Neurology, 2010
- EFNS guidelines on diagnosis and management of neuromyelitis opticaEuropean Journal of Neurology, 2010
- Rituximab inhibits B-cell receptor signalingBlood, 2010
- Treatment of Neuromyelitis Optica With RituximabArchives of Neurology, 2008
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple SclerosisNew England Journal of Medicine, 2008
- Brain Abnormalities in Neuromyelitis OpticaArchives of Neurology, 2006